Ontogeny Of Oral Epithelial Antimicrobial Peptides
口腔上皮抗菌肽的个体发育
基本信息
- 批准号:7415215
- 负责人:
- 金额:$ 32.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAge-YearsAntimicrobial Cationic PeptidesAppearanceAppendixBacteriaBacterial AdhesinsBeginning of LifeBiochemicalBiologicalBiological AssayBirthBody FluidsCell WallCharacteristicsChildComplexCross-Sectional StudiesCytoprotectionDataDefensinsDevelopmentDrug DesignElderlyEndoribonucleasesEnzyme-Linked Immunosorbent AssayEpidemiologic StudiesEpithelialEpithelial CellsEscherichia coliFusobacterium nucleatumFutureGene ExpressionGram-Negative BacteriaGrowthHIV-1Host DefenseHumanImmuneImmune responseImmune systemImmunologistIndividualInfantInfectionInflammationInjuryIntestinesInvadedInvestigationKnock-outLaboratoriesLeadLeukocyte L1 Antigen ComplexLifeLinkLongitudinal StudiesMembrane ProteinsMolecularMothersMucous MembraneNatural ImmunityNatureOralOral cavityOral mucous membrane structureOrganismOutcomePancreatic ribonucleasePeptidesPilot ProjectsPlayPorphyromonas gingivalisPost-Translational Protein ProcessingPropertyProteinsRNA InterferenceRangeRegulationResearch PersonnelResistanceResponse ElementsRibonucleasesRoleSLPI geneSalivaSalivarySourceStagingStructureStructure-Activity RelationshipSurfaceTooth structureTranscriptUp-RegulationViralWeaningWorkadrenomedullinage groupage relatedantimicrobialantimicrobial peptidebasebeta-Defensinsbeta-defensin-2commensal microbesdaydesigngenome databaseinfancyinterestmRNA Expressionmicrobialmucosal sitemutualismnovelnovel strategiesoral cavity epitheliumoral commensaloral tissueprogramspsoriasinresponse
项目摘要
DESCRIPTION (provided by applicant): The innate immune system, an evolutionarily ancient response, is believed to be present and functional at birth or within the first few days of life. However, the role commensal bacteria play in "turning on" innate immunity; i.e., regulating it's response, and at what ontogenic point in life this begins to occur is not known. Recent findings in our laboratory are leading us to conjecture that ontogeny of the oral innate immune response may be linked to colonizing organisms in the oral cavity. We recently discovered that Fusobacterium nucleatum, a ubiquitous Gram-negative bacterium of the human oral cavity, induces expression of epithelial cell derived human beta defensin -2 (hBD-2) and hBD-3 in normal oral epithelial cells (NHOECs), resulting in protection against invasion of Porphyromonas gingivalis, a major etiologic agent in periodontal destruction. Extensive biochemical and molecular biological work has identified an F. nucleatum outer membrane protein that induces these antimicrobial and immunoregulatory peptides. We refer to this protein as FAD-I for Fusobacterial associated defensin inducer. Additionally, preliminary cross-sectional data indicates that salivary hBD levels are significantly lower in infancy than in older age groups. We suspect that an age-related association with hBD induction, and possibly other epithelial cell derived antimicrobial peptides (AMPs), is correlated with colonization and persistence of FAD-I expressing F. nucleatum strains. Clearly we need to know more about this dynamic by (1) conducting epidemiologic studies to investigate AMP levels across the age spectrum to establish overall, age stratified and FAD-I associated distributions; (2) determining the inductive properties of FAD-I on AMPs and their subsequent contribution to NHOEC protection and (3) further characterizing the functionality of FAD-I by taking molecular and biochemical approaches to ascertain preliminary structure-function relationships in hBD induction. By better understanding the ontogenic spectrum of an individual's innate immune AMP profile, we may be able to identify individuals who are predisposed to mucosal infections. By uncovering potential beneficial commensal strategies with the host, as FAD-I appears to be, we may one day be able to exploit these strategies in protecting susceptible mucosal sites. FAD-I is a new discovery that warrants investigation into the possibility that it or its derivatives may provide a new direction into drug design that could be exploited locally to bolster Mother Nature's own defenses.
描述(由申请人提供):据信,先天免疫系统是一种进化的古老反应,在出生时或生命的前几天都存在和功能。但是,共生细菌在“打开”先天免疫中起着作用。即,调节其反应,以及在生活中开始发生什么生命点,尚不清楚。我们实验室中的最新发现使我们推测口腔先天免疫反应的个体可能与口腔中的生物存在有关。 We recently discovered that Fusobacterium nucleatum, a ubiquitous Gram-negative bacterium of the human oral cavity, induces expression of epithelial cell derived human beta defensin -2 (hBD-2) and hBD-3 in normal oral epithelial cells (NHOECs), resulting in protection against invasion of Porphyromonas gingivalis, a major etiologic agent in periodontal破坏。广泛的生化和分子生物学工作已经鉴定出一种f.核外膜蛋白,该蛋白诱导这些抗菌和免疫调节性肽。我们将此蛋白称为fAD-I用于梭菌相关的防御蛋白诱导蛋白。此外,初步横截面数据表明,婴儿期唾液HBD水平明显低于年龄段的年龄组。我们怀疑与HBD诱导的年龄相关,以及其他可能的上皮细胞衍生的抗菌肽(AMP)与定殖和表达FAD-1表达F.核菌株的FAD-I的持续性相关。显然,我们需要通过(1)进行流行病学研究以研究整个年龄频谱的AMP水平,以建立整体,年龄分层和FAD-I相关分布,以了解更多有关这种动态的信息; (2)确定FAD-I对AMPS的电感特性及其随后对NHOEC保护的贡献,以及(3)通过采用分子和生化方法来确定HBD诱导中FAD-I的功能。通过更好地理解个人先天免疫AMP谱的个体基础,我们也许能够识别出易于粘膜感染的个体。通过FAD-I似乎是与宿主一起发现潜在的有益的共生策略,我们有一天可能能够利用这些策略来保护易感粘膜部位。 FAD-I是一个新发现,需要调查其或其衍生物可能为药物设计提供新方向的可能性,该方向可以在本地利用,以增强大自然母亲的防御能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AARON WEINBERG其他文献
AARON WEINBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AARON WEINBERG', 18)}}的其他基金
Oral Mucosal Immunity in Vulnerable HIV Infected Populations
易受艾滋病毒感染人群的口腔粘膜免疫
- 批准号:
8462465 - 财政年份:2009
- 资助金额:
$ 32.47万 - 项目类别:
Oral Mucosal Immunity in Vulnerable HIV Infected Populations
易受艾滋病毒感染人群的口腔粘膜免疫
- 批准号:
7869420 - 财政年份:2009
- 资助金额:
$ 32.47万 - 项目类别:
Oral Mucosal Immunity in Vulnerable HIV Infected Populations
易受艾滋病毒感染人群的口腔粘膜免疫
- 批准号:
8527963 - 财政年份:2009
- 资助金额:
$ 32.47万 - 项目类别:
Oral Mucosal Immunity in Vulnerable HIV Infected Populations
易受艾滋病毒感染人群的口腔粘膜免疫
- 批准号:
8254426 - 财政年份:2009
- 资助金额:
$ 32.47万 - 项目类别:
Oral Mucosal Immunity in Vulnerable HIV Infected Populations
易受艾滋病毒感染人群的口腔粘膜免疫
- 批准号:
8070381 - 财政年份:2009
- 资助金额:
$ 32.47万 - 项目类别:
Oral Mucosal Immunity in Vulnerable HIV Infected Populations
易受艾滋病毒感染人群的口腔粘膜免疫
- 批准号:
7680509 - 财政年份:2009
- 资助金额:
$ 32.47万 - 项目类别:
Ontogeny Of Oral Epithelial Antimicrobial Peptides
口腔上皮抗菌肽的个体发育
- 批准号:
7609192 - 财政年份:2007
- 资助金额:
$ 32.47万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Regulation of Vascular Calcification by Adventitial Endothelial Cells
外膜内皮细胞对血管钙化的调节
- 批准号:
10642619 - 财政年份:2023
- 资助金额:
$ 32.47万 - 项目类别:
Hospice exposure and utilization among older African Americans with ADRD and their decisional support persons
患有 ADRD 的老年非洲裔美国人及其决策支持人员的临终关怀暴露和利用
- 批准号:
10679558 - 财政年份:2023
- 资助金额:
$ 32.47万 - 项目类别:
Social Connectedness and Health among Gender Minority People of Color
性别少数有色人种的社会联系和健康
- 批准号:
10650066 - 财政年份:2023
- 资助金额:
$ 32.47万 - 项目类别:
Vascular Determinants of Anesthesia-Induced Hypotension at the Extremes of Age
极端年龄时麻醉引起的低血压的血管决定因素
- 批准号:
10711597 - 财政年份:2023
- 资助金额:
$ 32.47万 - 项目类别:
Improving sleep and circadian functioning, daytime functioning, and well-being for midlife and older adults by improving patient memory for a transdiagnostic sleep and circadian treatment
通过改善患者对跨诊断睡眠和昼夜节律治疗的记忆,改善中年和老年人的睡眠和昼夜节律功能、日间功能和福祉
- 批准号:
10708424 - 财政年份:2023
- 资助金额:
$ 32.47万 - 项目类别: